GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (LSE:IMM) » Definitions » Net Interest Income (for Banks)

ImmuPharma (LSE:IMM) Net Interest Income (for Banks)


View and export this data going back to 2003. Start your Free Trial

What is ImmuPharma Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


ImmuPharma Business Description

Industry
Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease.